Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Actinium Pharmaceuticals Inc ATNM

Healthcare Biotechnology
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A... see more

Recent & Breaking News (NYSEAM:ATNM)

Actinium Announces Collaboration With Albert Einstein College of Medicine on New Actinium Program

Marketwired October 27, 2014

Final Reminder Related to Actinium's Key Opinion Leader Event Focused on Emerging Therapies for Acute Myeloid Leukemia on October 21st in New York City

Marketwired October 20, 2014

Actinium to Host Key Opinion Leader Event Focused on Emerging Therapies for Acute Myeloid Leukemia on October 21 in New York City

Marketwired October 14, 2014

RedChip Issues Research Profile on Actinium Pharmaceuticals

GlobeNewswire October 7, 2014

RedChip Announces Presentation Schedule for Its October 15-16 Online Investor Conference

GlobeNewswire October 6, 2014

Actinium to Present at the 14th Annual Biotech in Europe Forum for Global Partnering and Investment on September 30th

Marketwired September 25, 2014

Actinium Advisory Board Chairman to Participate in the Cancer Advance Boston: Focus on Innovation Conference at Harvard Medical School

Marketwired September 23, 2014

Actinium to Present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26th

Marketwired September 16, 2014

MD Anderson Department Chair Richard E. Champlin, M.D. Joins Actinium's Iomab(TM)-B Scientific Advisory Board

Business Wire September 10, 2014

Actinium Files Orphan Drug Application for Use of Actimab-A in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

Business Wire September 3, 2014

Actinium to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10th

Business Wire August 28, 2014

Actinium to Present at the Canaccord Genuity 34th Annual Growth Conference on August 13th

Business Wire August 5, 2014

Actinium Pharmaceuticals Provides Mid-Year Update Directed at Existing and Future Shareholders

Business Wire August 4, 2014

Baylor Sammons Cancer Center Joins as Clinical Trial Site for Actinium's Actimab-A Clinical Trial

Business Wire July 30, 2014

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg

GlobeNewswire July 24, 2014

Actinium Pharmaceuticals, Inc. Announces Launch of Additional Antibody Actinium-225 Labeling Program

Business Wire July 16, 2014

Actinium Announces Exercise of Greenshoe Option

Business Wire July 10, 2014

RedChip Announces Schedule for Its July 16-17 Global Online CEO Conference

GlobeNewswire July 8, 2014

Baylor Oncology Medical Director Joins Actinium's Iomab-B Scientific Advisory Board

Business Wire July 7, 2014

Actinium Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes

Business Wire July 1, 2014